Placebo Non-invasive Neuromodulation
Placebo Non-invasive Neuromodulation is a medical device with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
Effectiveness of NESA in the Treatment of Cancer Survivors
Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation
Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders
Clinical Trials (7)
Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
Effectiveness of NESA in the Treatment of Cancer Survivors
Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation
Usefulness of NESA Microcurrents in the Treatment of Children With Autism Spectrum Disorders
Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia
Non-invasive Neuromodulation NESA in Neuroefficiency in Basketball Players
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7